OpenAI launches Lockdown Mode and Elevated Risk warnings to protect ChatGPT against prompt-injection attacks and reduce data-exfiltration risks.

Despite rapid generation of functional code, LLMs are introducing critical, compounding security flaws, posing serious risks for developers.

Prompt injection vulnerabilities may never be fully mitigated as a category and network defenders should instead focus on ways to reduce their impact, government security experts have warned. Then ...

Computational and Communication Science and Engineering (CoCSE), The Nelson Mandela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania In the face of increasing cyberattacks, ...

SAP has released its November security updates that address multiple security vulnerabilities, including a maximum severity flaw in the non-GUI variant of the SQL Anywhere Monitor and a critical code ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Discover a smarter way to grow with Learn with Jay, your trusted source for mastering valuable skills and unlocking your full potential. Whether you're aiming to advance your career, build better ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Learn tech skills that help make daily caregiving tasks more ...

The FDA has approved lenacapvir, a twice-yearly injection to prevent HIV infection that could improve adherence rates compared to other PrEP medications. The drug, which will be sold under the brand ...

The US Food and Drug Administration has just approved lenacapavir, an injectable form of HIV prevention that is almost 100 percent effective and requires only two doses per year. Science magazine ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV, a move the company hailed as a major breakthrough in the fight against the sexually ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually ...